Non–blood product agents for bleeding disorders

Thomas G. DeLoughery

doi:10.1007/978-3-319-09312-3_13

Non–blood product agents for bleeding disorders

Thomas G. DeLoughery

Knight Cancer Institute

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

This chapter discussed the use of desmopressin, tranexamic acid, epsilon–aminocaproic acids, estrogens, and rVIIa. Several non–plasma–derived agents exist for therapy of bleeding disorders. All of these agents share the common qualities of being relatively nonspecific and having potential life–threatening complications.

Original language	English (US)
Title of host publication	Hemostasis and Thrombosis, Third Edition
Publisher	Springer International Publishing
Pages	63-65
Number of pages	3
ISBN (Electronic)	9783319093123
ISBN (Print)	9783319093116
DOIs	https://doi.org/10.1007/978-3-319-09312-3_13
State	Published - Jan 1 2015

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-319-09312-3_13

Cite this

@inbook{53192e3b00444660a3b0f9369e43153c,

title = "Non–blood product agents for bleeding disorders",

abstract = "This chapter discussed the use of desmopressin, tranexamic acid, epsilon–aminocaproic acids, estrogens, and rVIIa. Several non–plasma–derived agents exist for therapy of bleeding disorders. All of these agents share the common qualities of being relatively nonspecific and having potential life–threatening complications.",

author = "DeLoughery, {Thomas G.}",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 1999, 2004, 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-319-09312-3_13",

language = "English (US)",

isbn = "9783319093116",

pages = "63--65",

booktitle = "Hemostasis and Thrombosis, Third Edition",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Non–blood product agents for bleeding disorders

AU - DeLoughery, Thomas G.

N1 - Publisher Copyright: © Springer International Publishing Switzerland 1999, 2004, 2015.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - This chapter discussed the use of desmopressin, tranexamic acid, epsilon–aminocaproic acids, estrogens, and rVIIa. Several non–plasma–derived agents exist for therapy of bleeding disorders. All of these agents share the common qualities of being relatively nonspecific and having potential life–threatening complications.

AB - This chapter discussed the use of desmopressin, tranexamic acid, epsilon–aminocaproic acids, estrogens, and rVIIa. Several non–plasma–derived agents exist for therapy of bleeding disorders. All of these agents share the common qualities of being relatively nonspecific and having potential life–threatening complications.

UR - http://www.scopus.com/inward/record.url?scp=84944628817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944628817&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-09312-3_13

DO - 10.1007/978-3-319-09312-3_13

M3 - Chapter

AN - SCOPUS:84944628817

SN - 9783319093116

SP - 63

EP - 65

BT - Hemostasis and Thrombosis, Third Edition

PB - Springer International Publishing

ER -

Non–blood product agents for bleeding disorders

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this